There is no current national screening programme for prostate cancer; the committee that decides these things is looking into ...

Prostate cancer cases have increased since 2014, with a 3% annual increase, likely due to changes in screening recommendations that may be resulting in more advanced and terminal cases of the disease.

THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

Prostate cancer is the malignant growth of cells in the prostate, a walnut-sized gland below the bladder, that is responsible ...

Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital, and four other institutions ...

The prostate health index (PHI) is a newer blood test that more accurately assesses your risk of prostate cancer than the ...

Dr. Paul Gellhaus says PSA testing and modern biopsy methods ease fears and reassure patients, making early prostate cancer ...

For decades, it has been known that prostate specific antigen ‒ or PSA ‒ tests are a flawed way to diagnose prostate cancer. Many men have a high PSA without having cancer. Others have low PSA that ...

Medicare covers one annual prostate-specific antigen (PSA) test for people with prostates if they meet the eligibility guidelines and the test is medically necessary. Medicare typically covers one ...

Medically reviewed by Doru Paul, MD A digital rectal exam (DRE) is a procedure where a doctor inserts a gloved, lubricated ...

Primary care clinicians need to do a better job of informing Black men and other patients at high risk of dying from prostate ...